Guangzhou yunyu trading
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Guangzhou yunyu trading between 26 Jan 2026 and 16 Mar 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Guangzhou yunyu trading
Retatrutide
Tested 4 Samples
Last test 16 Mar 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Guangzhou yunyu trading
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
16 Mar 2026
First
26 Jan 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 16 Mar 2026 | View | 20mg | 19.3mg | -3.5% | 99.90% | below LOQ | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 10 Mar 2026 | View | 10mg | 10.7mg | +7.0% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 15 Feb 2026 | View | 10mg | 10.5mg | +5.0% | 99.60% | n/a | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab G | Public | |
| 26 Jan 2026 | View | 30mg | 30.9mg | +3.0% | 99.80% | n/a | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab G | Public | |